Abstract
Background
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation therapy used to improve lower extremity motor function in patients with spinal cord injury (SCI). However, its efficacy remains inconsistent.
Objective
This meta-analysis aimed to comprehensively assess the effectiveness and safety of rTMS for lower extremity motor function, spasticity, and walking ability in SCI patients.
Methods
Up to April 30, 2025, randomized controlled trials (RCTs) were searched by PubMed, Web of Science, MEDLINE, Ovid, and the Cochrane Central Register of Controlled Trials. Primary outcomes were Lower Extremity Motor Score (LEMS) and Lower Modified Ashworth Scale (LMAS); secondary outcomes included Spinal Cord Assessment Tool for Spasticity (SCATS), Hmax/Mmax amplitude ratio (H/M ratio), 10-Meter Walking Test (10 WMT), Walking Index for Spinal Cord Injury-II (WISCI-II), and gait velocity. Subgroup analyses were performed by injury duration.
Results
Fifteen RCTs (260 participants) were included. rTMS significantly improved lower extremity strength measured by LEMS (SMD = 0.98, 95% CI = 0.61 to 1.36, P < 0.00001) regardless of injury duration and decrease spasticity measured by LMAS (SMD = −0.46, 95% CI = −0.85 to −0.08, P = 0.02). No significant changes were found for spasticity assessed by SCATS or H/M ratio, or for walking outcomes (10MWT, WISCI-II, gait velocity).
Conclusion
rTMS effectively enhances muscle strength and reduces spasticity in SCI patients, but its impact on walking ability is limited. Further high-quality trials are needed to confirm these findings.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
